Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study

Completed

Conditions studied: Arthritis, Rheumatoid, Medication Adherence

In brief

This study aims to provide preliminary evidence of the validity of a sensor-based assessment of rheumatoid arthritis (RA) symptoms, and to collect structured qualitative feedback from RA Enbrel patients regarding the potential of a future biosensor/PRO mHealth application. The investigators' overarching hypothesis is that if patients have better and more timely information about whether Enbrel is working, then they will become more empowered and engaged in their treatment, more curious about how it may - or may not - be working, and potentially more compliant with therapy. However, this hypothesis remains largely untested.

Key facts

Study ID

NCT02296632

Run by

Cedars-Sinai Medical Center

People needed

7

Starts

2014-11-01

Expected to finish

2015-08-01

Last updated by the study team

2015-08-19

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Enbrel users between week -2 and week 5 of therapy, inclusive.
• Current active prescription for Enbrel with intent to use.
• 21 years or older.
• English speaking
• Have an understanding, ability, and willingness to fully comply with study procedures and restrictions.

You may not qualify if…

• Allergic to latex or dry natural rubber
• Using a pacemaker, implantable cardiac defibrillator, neurostimulator, hearing aids, cochlear implants or other electronic medical equipment.

Where it is running

• Cedars-Sinai Medical Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.